Cargando…
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
Autores principales: | Finkelstein, David I., Billings, Jessica L., Adlard, Paul A., Ayton, Scott, Sedjahtera, Amelia, Masters, Colin L., Wilkins, Simon, Shackleford, David M., Charman, Susan A., Bal, Wojciech, Zawisza, Izabela A., Kurowska, Ewa, Gundlach, Andrew L., Ma, Sheri, Bush, Ashley I., Hare, Dominic J., Doble, Philip A., Crawford, Simon, Gautier, Elisabeth C. L., Parsons, Jack, Huggins, Penny, Barnham, Kevin J., Cherny, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482648/ https://www.ncbi.nlm.nih.gov/pubmed/34588001 http://dx.doi.org/10.1186/s40478-021-01258-8 |
Ejemplares similares
-
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
por: Finkelstein, David I., et al.
Publicado: (2017) -
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy
por: Finkelstein, David I., et al.
Publicado: (2022) -
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2022) -
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
por: Diwakarla, Shanti, et al.
Publicado: (2021) -
A novel approach to rapidly prevent age-related cognitive decline
por: Adlard, Paul A, et al.
Publicado: (2014)